Amlodipin-Valsartan-HCT-Mepha 5mg/160mg/12.5mg
Amlodipin-Valsartan-HCT-Mepha 5mg/160mg/12.5mg is a medicine authorised by Swissmedic under authorisation number 65890. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 02 November 2016 and the authorisation is valid without a time limit. ATC code C09DX01 places the medicine in the group Agents acting on the renin-angiotensin system.
| Authorisation number | 65890 |
|---|---|
| Name | Amlodipin-Valsartan-HCT-Mepha 5mg/160mg/12.5mg |
| Full name | Amlodipin-Valsartan-HCT-Mepha 5mg/160mg/12.5mg, Filmtabletten |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C09DX01 |
| First authorisation | 02 November 2016 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Amlodipin-Valsartan-HCT-Mepha 5mg/160mg/12.5mg, Filmtabletten | B | 02 November 2016 |
| 2 | Amlodipin-Valsartan-HCT-Mepha 5mg/160mg/25mg, Filmtabletten | B | 02 November 2016 |
| 3 | Amlodipin-Valsartan-HCT-Mepha 10mg/160mg/12.5mg, Filmtabletten | B | 02 November 2016 |
| 4 | Amlodipin-Valsartan-HCT-Mepha 10mg/160mg/25mg, Filmtabletten | B | 02 November 2016 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Tablette(n) | C09DX01 | 02.07.2. | B |
| 2 | 98 | Tablette(n) | C09DX01 | 02.07.2. | B |
| 9 | 100 | Tablette(n) | C09DX01 | 02.07.2. | B |
| 3 | 28 | Tablette(n) | C09DX01 | 02.07.2. | B |
| 4 | 98 | Tablette(n) | C09DX01 | 02.07.2. | B |
| 10 | 100 | Tablette(n) | C09DX01 | 02.07.2. | B |
| 5 | 28 | Tablette(n) | C09DX01 | 02.07.2. | B |
| 6 | 98 | Tablette(n) | C09DX01 | 02.07.2. | B |
| 11 | 100 | Tablette(n) | C09DX01 | 02.07.2. | B |
| 7 | 28 | Tablette(n) | C09DX01 | 02.07.2. | B |
| 8 | 98 | Tablette(n) | C09DX01 | 02.07.2. | B |
| 12 | 100 | Tablette(n) | C09DX01 | 02.07.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Amlodipin-Valsartan-HCT-Mepha 5mg/160mg/12.5mg authorised in Switzerland?
Yes. Amlodipin-Valsartan-HCT-Mepha 5mg/160mg/12.5mg is authorised by Swissmedic under authorisation number 65890, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Amlodipin-Valsartan-HCT-Mepha 5mg/160mg/12.5mg have?
Amlodipin-Valsartan-HCT-Mepha 5mg/160mg/12.5mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Amlodipin-Valsartan-HCT-Mepha 5mg/160mg/12.5mg?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.